Escalated dose, First relapse, Multiple myeloma, VRD
dx.doi.org/10.3324/haematol.2015.132431, hdl.handle.net/1765/91962
Haematologica
Erasmus MC: University Medical Center Rotterdam

Broijl, A, Kersten, M.J, Alemayehu, W.G, Levin, M.-D, de Weerdt, O, Vellenga, E, … Sonneveld, P. (2016). Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma. Haematologica, 101(4), e149–e152. doi:10.3324/haematol.2015.132431